This, in turn, initiated the activation of the Src/Akt/ERK-mediated anti-apoptotic program, thereby contributing to the development of 5-FU resistance in colorectal cancer HT29 cells [50] (Figure 3). Here, AKT1 is linked to colorectal cancer.